Brief: Mega Genomics Announces Termination Of Huang Yufeng's Role As Chief Executive Officer
17/01/2024 15:05
Jan 17 (Reuters) - Mega Genomics Ltd 6667.HK :
* TERMINATION OF HUANG YUFENG'S ROLE AS CHIEF EXECUTIVE
OFFICER
* ROLE OF HUANG YUFENG AS AN EXECUTIVE DIRECTOR HAS BEEN
TERMINATED
* JIANG JING, AN EXECUTIVE DIRECTOR WILL ASSUME
RESPONSIBILITIES
OF CHIEF EXECUTIVE OFFICER
Further company coverage: 6667.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mega Genomics
See all newsBrief: Mega Genomics Expects FY2025 Revenue Of RMB240-250 Million
Brief: Mega Genomics Says Trading In Shares Of Company Will Be Suspended From On 1 April
Brief: Mega Genomics Announces Termination Of Huang Yufeng's Role As Chief Executive Officer
Brief: Meinian Onehealth Healthcare Signs Genetic Testing Project Cooperation Agreement
Brief: Mega Genomics Sees Loss Attributable For Year RMB13 Million To RMB22 Million